title: The clinical course of idiopathic dilated cardiomyopathy. A population-based study.
abstract: OBJECTIVE
  To describe the prognosis of individuals with idiopathic dilated cardiomyopathy in a population-based sample and to compare this with the prognosis of patients in a previous referral center case series of idiopathic dilated cardiomyopathy.
  
  
  METHODS
  Cohort study.
  
  
  METHODS
  Population-based in Olmsted County, Minnesota.
  
  
  METHODS
  Forty residents of Olmsted County, Minnesota with idiopathic dilated cardiomyopathy initially diagnosed between 1975 and 1984 who were followed through 1 July 1989 and 104 patients from a Mayo Clinic referral case series from 1960 to 1973.
  
  
  METHODS
  Survival for the population-based cohort at 1 year and 5 years.
  
  
  RESULTS
  Survival at 1 year differed dramatically between the population-based cohort and the referral case series at 1 year (95% compared with 69%, respectively) and at 5 years (80% compared with 36%, respectively) (P less than 0.001). Long-term survival for the population-based cohort was nonetheless impaired when compared with an age- and sex-matched cohort, that is, the 1980 Minnesota white population (8-year survival: observed, 58% compared with expected, 83%; P less than 0.001). Among community patients, older age (adjusted Cox model hazard ratio for 10-year increase in age, 1.59; 95% CI, 1.08 to 2.35) and lower left ventricular ejection fraction (adjusted hazard ratio for 10% decrease, 1.90; CI, 1.04 to 3.50) were independently associated with impaired survival.
  
  
  CONCLUSIONS
  These population-based data challenge the clinical perception of the clinical course of idiopathic dilated cardiomyopathy based on referral practice prognostic studies and suggest that the clinical course of this condition may be more favorable than previously recognized.
authors.affiliation: Mayo Clinic, Rochester, Minnesota.
authors.forename: D D
authors.initials: DD
authors.lastname: Sugrue
authors.forename: R J
authors.initials: RJ
authors.lastname: Rodeheffer
authors.forename: M B
authors.initials: MB
authors.lastname: Codd
authors.forename: D J
authors.initials: DJ
authors.lastname: Ballard
authors.forename: V
authors.initials: V
authors.lastname: Fuster
authors.forename: B J
authors.initials: BJ
authors.lastname: Gersh
mesh_terms: D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012017:Referral and Consultation; D012307:Risk Factors; D015996:Survival Rate